Postdoctoral Research Fellows – Cancer Epigenomics Research bei The University of Queensland

• Frazer Institute

• Three (3) full-time, fixed-term positions through to 31 December 2026  

• Base salary will range from $82,057 – $109,246 (Academic Level A) + 17% Superannuation

• Based at the Translational Research Institute at our Dutton Park campus

About These Opportunities 

We are seeking three Postdoctoral Research Fellows to join our world-class research team at the Frazer Institute to support and drive cancer epigenomics research. We are specifically looking for early career researchers who have a passion for epigenetics and a keen interest in translating research into clinical applications. Work with us to create real change, and we’ll help you get the best start to your academic career at one of Australia’s leading universities!

Working under the guidance and direction of Associate Professor Jason Lee, successful candidates will conduct vital research in cancer epigenomics with the aim of developing novel biomarkers and therapeutics. Specifically, you will support the major project “Understanding and Overcoming Resistance to new and emerging Therapies in Uveal Melanoma” which is supported by the US Department of Defense in collaboration with UNSW, Macquarie University and pharmaceutical companies.

These three research focused opportunities are being sought as follows:

• Positions 1 and 2 will conduct research into melanoma treatment resistance. Ideal candidates will have knowledge of molecular (CRISPR screens, Chromatin IP, ATAC-seq) and cellular biology (cell death mechanisms, immunology), and experience with animal models and organoid cultures.

• Position 3 will focus on Bioinformatics. The successful candidate will develop computational tools for analysing gene expression (single cell, spatial) and metabolomic data in the context of cancer including melanoma and pancreatic cancer. You will lead the application of AI and machine learning to identify novel therapeutic targets and advance precision medicine approaches.

For further information, please click here to view the full appointment booklet. If you are unable to access this link, please email [email protected] for a copy of the booklet.

We encourage all applications, both domestic and international. Subject to individual eligibility, we may support the successful applicant with obtaining employer-sponsored work rights.

Questions?  

For more information about these opportunities, please contact Associate Professor Jason Lee at [email protected].

For application inquiries, please reach out to the Talent Acquisition team at [email protected], stating the job reference number (below) in the subject line. 
 

Want to Apply?  

We welcome applications from all individuals and are committed to an inclusive and accessible recruitment process. To be considered, please ensure you upload:

• Resume

• Cover letter addressing the relevant ‘About You’ section found within the appointment booklet above 

Applicants should specifically address in your cover letter which position/s you are applying for (Positions 1 and 2, or Position 3).

Our strength as an institution lies in our diverse colleagues. We're dedicated to equity, diversity, and inclusion, fostering an environment that mirrors our wider community. We're committed to attracting, retaining, and promoting diverse talent. If you require an alternative method to submit your application due to accessibility needs or personal circumstances, please contact [email protected]. 

Other Information  

UQ is committed to a fair, equitable and inclusive selection process, which recognises that some applicants may face additional barriers and challenges which have impacted and/or continue to impact their career trajectory. Candidates who don’t meet all criteria are encouraged to apply and demonstrate their potential. The selection panel considers both potential and performance relative to opportunities when assessing suitability for the role.  

Applications close Thursday 25 September 2025 at 11.00pm AEST (Job Reference Number: R-45331).